Alector, Inc. (ALEC)
2.505
-0.22
(-7.90%)
USD |
NASDAQ |
Sep 03, 16:00
2.50
0.00 (0.00%)
After-Hours: 18:24
Alector Shareholders Equity (Quarterly) : -9.97M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.97M |
| March 31, 2026 | 10.38M |
| December 31, 2025 | 30.65M |
| September 30, 2025 | 57.71M |
| June 30, 2025 | 71.18M |
| March 31, 2025 | 94.61M |
| December 31, 2024 | 126.80M |
| September 30, 2024 | 118.93M |
| June 30, 2024 | 150.57M |
| March 31, 2024 | 178.91M |
| December 31, 2023 | 134.16M |
| September 30, 2023 | 162.56M |
| June 30, 2023 | 196.31M |
| March 31, 2023 | 183.02M |
| December 31, 2022 | 214.44M |
| September 30, 2022 | 253.10M |
| June 30, 2022 | 288.52M |
| March 31, 2022 | 267.54M |
| Date | Value |
|---|---|
| December 31, 2021 | 300.72M |
| September 30, 2021 | 335.89M |
| June 30, 2021 | 184.52M |
| March 31, 2021 | 227.83M |
| December 31, 2020 | 267.53M |
| September 30, 2020 | 310.19M |
| June 30, 2020 | 355.33M |
| March 31, 2020 | 391.73M |
| December 31, 2019 | 194.74M |
| September 30, 2019 | 218.59M |
| June 30, 2019 | 245.72M |
| March 31, 2019 | 266.19M |
| December 31, 2018 | 113.12M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 25.45M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 202.86M |
| Total Liabilities (Quarterly) | 212.82M |
| Debt to Equity Ratio | -3.286 |
| Current Ratio | 5.260 |
| Net Debt Paydown Yield | 0.74% |